stockrowTrulieve Cannabis Corp. (TRLV) vs Xeris Biopharma Holdings, Inc. (XERS)
- Trulieve Cannabis Corp. TRLV 11.07 −4.57%
- Xeris Biopharma Holdings, Inc. XERS 12.95 +23.80%
Trulieve Cannabis Corp. and Xeris Biopharma Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. Xeris Biopharma Holdings, Inc. is the larger, with a market value of $2.4B against $2.1B — 1.1× the size. Xeris Biopharma Holdings, Inc. grew revenue faster over the last twelve months: 38.4% against −9.09%. Xeris Biopharma Holdings, Inc. has the higher net margin (−1.76% vs −41.2%) and the higher return on invested capital (27.2% vs 0.00%). Across the 19 metrics below, Xeris Biopharma Holdings, Inc. leads on 10 and Trulieve Cannabis Corp. on 9.
Valuation
Profitability
| Metric | TRLV | XERS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 60.64% | 87.38% | 53.51% |
| Operating margin | 0.00% | 12.70% | 0.00% |
| Net margin | (41.22%) | (1.76%) | (2.45%) |
| Free cash flow margin | 22.43% | 20.00% | 0.00% |
| Return on equity | (45.52%) | (27.11%) | (0.80%) |
| Return on assets | (17.61%) | (1.64%) | (1.67%) |
| Return on invested capital | 0.00% | 27.22% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack